Related Experiment Videos
A lethal disease model for hantavirus pulmonary syndrome
J W Hooper1, T Larsen, D M Custer
1Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland 21702, USA. jay.hooper@det.amedd.army.mil
Virology
|October 17, 2001
Summary
A new Syrian hamster model using Andes virus (ANDV) offers a breakthrough for studying hantaviruses. This lethal model closely mimics human hantavirus pulmonary syndrome (HPS), aiding vaccine and therapy development.
Area of Science:
- Virology
- Infectious Diseases
- Animal Models
Background:
- Hantaviruses cause hemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome (HPS) in humans.
- Developing effective vaccines and treatments for HFRS and HPS is challenging due to the lack of suitable animal models.
Purpose of the Study:
- To establish a practical and lethal animal model for hantaviruses that cause HPS.
Main Methods:
- Adult Syrian hamsters were infected with Andes virus (ANDV), a South American hantavirus.
- Observed and documented disease progression, symptoms, and pathological findings.
Main Results:
- Andes virus infection proved highly lethal in Syrian hamsters.
- The induced disease exhibited characteristics mirroring human HPS, including rapid respiratory distress, pulmonary edema, and pleural effusion.
Conclusions:
- This study reports the first lethal animal model for hantaviruses that recapitulates key features of human HPS.
- The Syrian hamster model provides a valuable platform for advancing research into hantavirus pathogenesis and therapeutic strategies.